Literature DB >> 21327012

Case control study to determine the factors associated with leprosy in the sene district, brong ahafo region of ghana.

A A Ofosu1, Gy Bonsu.   

Abstract

INTRODUCTION: There are currently an estimated 10-12 million cases of leprosy in the world. In Sene District of the Brong Ahafo Region of Ghana the prevalence of leprosy is 2.4/10,000 of the population. Most of these cases are children, indicating that new infections are still occurring in the communities.
OBJECTIVES: To identify factors associated with leprosy in the Sene District in order to implement an effective strategy to eliminate leprosy from the district.
DESIGN: Case-control study.
METHOD: The cases were selected from a register of active leprosy cases. Controls were matched for age, and sex. For every one case identified two controls were selected.
RESULTS: Of the twenty four cases identified, eighteen (75%) were paucibacillary and six (25%) were multibacillary leprosy. Most of the leprosy lesions were found on the trunk (25%) and upper limbs (37.5%). 13(54.2%) of the cases were under twenty years old. From the study, contact with someone with leprosy in the same house is associated with having leprosy. (OR -3.4 95%CI 1.09-10.8 p=0.017). Not having BCG vaccination is associated with having leprosy (OR 11 95%CI 2.12-76.17)p=0.0005).
CONCLUSION: The findings confirm that close contact with a patient with leprosy facilitates transmission of M. leprae. To reduce leprosy in the Sene District there is the need to increase BCG vaccination coverage in children and ensure that all contacts of cases are thoroughly screened for the disease and treated. Health workers in the district need to be trained to identify leprosy lesions.

Entities:  

Keywords:  Ghana; Leprosy; M. leprae; case control study; transmission

Year:  2010        PMID: 21327012      PMCID: PMC2996841          DOI: 10.4314/gmj.v44i3.68891

Source DB:  PubMed          Journal:  Ghana Med J        ISSN: 0016-9560


  5 in total

1.  Immunization against leprosy: progress and prospects.

Authors:  S K Noordeen; H Sansarricq
Journal:  Bull Pan Am Health Organ       Date:  1984

2.  The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.

Authors:  S P Zodpey
Journal:  Indian J Public Health       Date:  2004 Apr-Jun

3.  [The protective efficacy of BCG against leprosy in São Paulo, Brazil].

Authors:  C Lombardi; E S Pedrazzani; J C Pedrazzani; P Ferreira Filho; F Zicker
Journal:  Bol Oficina Sanit Panam       Date:  1995-11

4.  Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi.

Authors:  J M Pönnighaus; P E Fine; J A Sterne; R J Wilson; E Msosa; P J Gruer; P A Jenkins; S B Lucas; N G Liomba; L Bliss
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

5.  Leprosy in Nkhotakota District Hospital.

Authors:  J E Chisi; A Nkhoma; Y Zverev; H Misiri; O O Komolafe
Journal:  East Afr Med J       Date:  2003-12
  5 in total
  1 in total

1.  Caregivers' views on stigmatization and discrimination of people affected by leprosy in Ghana.

Authors:  Emmanuel Asampong; Mavis Dako-Gyeke; Razak Oduro
Journal:  PLoS Negl Trop Dis       Date:  2018-01-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.